Translational Development Acquisition Corp. Units

NASDAQ:TDACU USA Shell Companies
Market Cap
$98.68K
Market Cap Rank
#16743 Global
#6420 in USA
Share Price
$10.44
Change (1 day)
+0.00%
52-Week Range
$10.13 - $10.52
All Time High
$10.52
About

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Translational Development Acquisition Corp. Units (TDACU) - Total Liabilities

Latest total liabilities as of September 2025: $6.46 Million USD

Based on the latest financial reports, Translational Development Acquisition Corp. Units (TDACU) has total liabilities worth $6.46 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Translational Development Acquisition Corp. Units - Total Liabilities Trend (2017–2024)

This chart illustrates how Translational Development Acquisition Corp. Units's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Translational Development Acquisition Corp. Units Competitors by Total Liabilities

The table below lists competitors of Translational Development Acquisition Corp. Units ranked by their total liabilities.

Liability Composition Analysis (2017–2024)

This chart breaks down Translational Development Acquisition Corp. Units's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.19 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Translational Development Acquisition Corp. Units's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Translational Development Acquisition Corp. Units (2017–2024)

The table below shows the annual total liabilities of Translational Development Acquisition Corp. Units from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 $6.25 Million +1125.83%
2023-12-31 $509.68K +10.96%
2022-12-31 $459.34K -95.60%
2020-12-31 $10.43 Million +72.43%
2019-12-31 $6.05 Million +1.00%
2018-12-31 $5.99 Million +1041.03%
2017-12-31 $525.00K --